中国地方医院12年室间隔缺损介入治疗大数据分析  

Large data analysis of 12-year interventional treatment of ventricular septal defect in local hospitals in China

作　　者：蒋世良 张戈军 JIANG Shi-liang;ZHANG Ge-jun(Department of Structural Heart Disease,Fuwai Hospital,National Center for Cardiovascular Disease of China,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China)

机构地区：[1]中国医学科学院、北京协和医学院、国家心血管病中心、阜外医院结构性心脏病中心,北京100037

出　　处：《心脏杂志》2021年第4期364-368,共5页Chinese Heart Journal

摘　　要：目的分析中国地方医院12年先天性心脏病(先心病)室间隔缺损(VSD)介入治疗的状况。方法搜集并整理国家卫生健康委员会先心病介入网络直报系统的数据,分析自2009年1月~2020年12月经皮VSD介入治疗的状况。结果12年中国150家地方医院共完成经皮VSD封堵术58,156例,技术成功率95.990%,严重并发症发生率0.349%,病死率0.021%。结论室间隔缺损封堵术是一种有效的介入方法,近期疗效可靠,远期疗效仍需进一步观察。AIM To analyze the interventional treatment of ventricular septal defects(VSDs)for congenital heart disease in local hospitals in China.METHODS The data of the network direct report system for congenital heart disease of National Health Commission were collected and the status of percutaneous closure of VSDs from January 2009 to December 2020 was analyzed.RESULTS A total of 58,156 cases of percutaneous closure of VSD were performed in 150 local hospitals in China in the 12 years.The technical success rate was 95.990%,the rate of serious complication was 0.353%and in-hospital mortality was 0.021%.CONCLUSION Percutaneous closure of VSDs is safe and effective.The long-term outcome for patients with device closure of VSDs remains to be determined.

关 键 词：心脏血管病 先天性 室间隔缺损 介入治疗 

分 类 号：R541.1[医药卫生—心血管疾病]